D-1057-2017 Class II Terminated

Recalled by PD-Rx Pharmaceuticals, Inc. — Oklahoma City, OK

FDA drug recall D-1057-2017 was initiated by PD-Rx Pharmaceuticals, Inc. on July 28, 2017 and is designated Class II. Reason for recall: Failed Tablet/Capsule Specification: out of specification for tablet weight. The recall status is terminated (terminated December 6, 2017). Affected quantity: 100 bottles.

Recall Details

Product Type
Drugs
Report Date
August 9, 2017
Initiation Date
July 28, 2017
Termination Date
December 6, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
100 bottles

Product Description

Famotidine USP 20 mg, 30 tablets bottle, Rx, PKG By; PD Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127 --- NDC 55289-765-30

Reason for Recall

Failed Tablet/Capsule Specification: out of specification for tablet weight.

Distribution Pattern

Nationwide

Code Information

Lot: A17F55 Exp. 06/30/2018